Durvalumab in Pediatric and Adolescent Patients
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2510924 and Durvalumab in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Eribulin and Lenvatinib in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
- Status
- TERMINATED
- Phase
- PHASE2
Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Medical Treatment Decision Making Using Adaptive Conjoint Analysis
- Status
- TERMINATED
- Phase
- N/A
Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+
- Status
- TERMINATED
- Phase
- PHASE1